Skip to content
Medical Health Aged Care

C3i Center Inc is First CDMO in Canada to Receive Approval for a Drug Establishment License to Commercially Produce Cell Therapy Drug Products

C3i Center Inc 2 mins read

Company awarded commercial Drug Establishment License (DEL) for Canada following successful inspection of C3i’s contract development and manufacturing organization (CDMO) facility.


MONTREAL--BUSINESS WIRE--

C3i Center Inc (C3i) announced it has received regulatory approval, in the form of a Drug Establishment License (DEL), to commercially produce cell therapies, making C3i the first CDMO in Canada to achieve this milestone.

The approval follows an inspection by the cell and gene therapy experts from Health Canada. The DEL approval recognizes C3i as having industry-leading expertise, regulatory know-how, and strong quality standards.

“The C3i team worked hard to meet the requirements of a DEL and are proud that we received approval from Health Canada to commercially manufacture cell therapies.” – Louisa Petropoulos, CEO of C3i. “We are excited to be the first CDMO in Canada to reach this milestone, and there is more to come. Our goal is to manufacture cell and gene therapies for the global market. We expect to have the European Medicines Agency (EMA) conduct their inspection later this fall.”

C3i supports its clients in process development, scale-up and manufacturing for phase 1 to phase 3 clinical trials, as well as commercial cell and gene-modified cell therapies. C3i continues to expand its capabilities to include the production of viral vectors, exosomes, and other autologous and allogeneic cellular therapies.

About C3i Center Inc

C3i is a full-service, in-house CDMO with a vision to make life-saving cell and gene therapies available to everyone who needs them. C3i provides services to biotechnology companies, academic research groups, and pharmaceutical companies, supporting the advancement and commercialization of innovative technologies. C3i’s dedicated team is focused on providing clients with tailored services to meet their specific needs, expediting their innovative pipeline from development to commercial. C3i prides itself on delivering on-time, cost-efficient quality results. In-house services include phase-appropriate quality control testing, biomarker discovery, immune monitoring and diagnostic testing with College of American Pathologists (CAP)-accredited laboratories.

To learn more about who we are, visit www.c3icenter.com and for business inquiries, please contact our VP of Business Development, Sandra Donaldson, at sdonaldson@centrec3i.com.


Contact details:

sdonaldson@centrec3i.com

Media

More from this category

  • Business Company News, Medical Health Aged Care
  • 15/07/2024
  • 11:55
Jane Morgan Management

Heramed Limited (ASX:HMD) and UTS Sign Five-Year Strategic Partnership Focused on Care and Wellbeing of Women and Babies

Melbourne, Australia – 15 July 2024 | Heramed Ltd (ASX: HMD) ("Heramed" or the "Company"), a pioneering medical data and technology company transforming maternity care, is pleased to announce the signing of a five-year Strategic Partnership Agreement (SPA) with the University of Technology Sydney (UTS). This partnership is led by UTS's INSIGHT Health Research Institute, a renowned centre for innovative health solutions. Key Highlights: Strategic Partnership: Heramed and UTS have entered a five-year strategic partnership through the leadership of INSIGHT Health Research Institute, focusing on improving the care and wellbeing of women and babies. Collaboration Scope: UTS, a leading Australian…

  • Contains:
  • Medical Health Aged Care
  • 15/07/2024
  • 11:38
NewDirection Care - Media Release

MINISTER WELLS WELCOMED TO A WARM VISIT AND TOUR OF NEWDIRECTION CARE MICROTOWN

NewDirection Care welcomed the Minister for Aged Care and Sport the Hon Anika Wells to their MICRO TOWN® community in Bellmere last week. The first of its kind in Australia, MICRO TOWN® is an aged care model resembling a typical suburban community equipped with a grocery store, community centre, hairdressers, and much more. “The residents and our team were delighted to have the opportunity to interact with Minister Wells and to showcase our community and explain why our model is so different to every other residential aged care,” said Natasha Chadwick, Founder and Managing Director of NewDirection Care. “The Minister’s…

  • Contains:
  • General News, Medical Health Aged Care
  • 15/07/2024
  • 09:39
HCF

HCF Research Foundation funds trial exploring new treatment to prevent chronic back pain

MONDAY, 15 JULY 2024: HCF Research Foundation, Australia’s leading non-government funder of health services research, is supporting a groundbreaking three-year project led by Dr…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.